Infoscience

Patent

Drug Combination for Treatment of Proliferative Diseases

Angiogenesis inhibitory drug combination obtained according to a specific algorithm, preferably a FSC, in which an initial combination of drugs is iteratively adjusted. The drug combination according to the invention may advantageously comprise a RAPTA-C compound. In a more specific case the combination comprises RAPTA-C and eriotinib.

Fulltext

  • There is no available fulltext. Please contact the lab or the authors.

Related material

Contacts